ResearcherJikei University School of MedicineActive in the last 2 years
Shintaro Tsukinaga
Matched on OpenAlex author ID A5110967030. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable … Co-author DOI 10.1136/jitc-2024-009765↗
- Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy. Co-author DOI 10.3748/wjg.v21.i39.11168↗
- Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0314↗
- Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. Co-author DOI 10.1179/1973947813y.0000000150↗
- Current immunotherapeutic approaches in pancreatic cancer. Co-author DOI 10.1155/2011/267539↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shigeo Koido · 4 shared papers, 2011–2024 · strength 0.26
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. DOI 10.1179/1973947813y.0000000150↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Shin Kan · 2 shared papers, 2014–2024 · strength 0.21
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Shigetaka Shimodaira · 2 shared papers, 2014–2024 · strength 0.21
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Haruo Sugiyama · 2 shared papers, 2014–2024 · strength 0.21
- Paper Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulat… DOI 10.1136/jitc-2024-009765↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Masamori Shimabuku · 1 shared paper, 2024 · strength 0.18
- Toshifumi Ohkusa · 1 shared paper, 2024 · strength 0.18
- Zensho Ito · 1 shared paper, 2024 · strength 0.18
- Masayuki Saruta · 1 shared paper, 2024 · strength 0.18
- Hisao Tajiri · 3 shared papers, 2011–2014 · strength 0.09
- Paper Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. DOI 10.1179/1973947813y.0000000150↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Paper Current immunotherapeutic approaches in pancreatic cancer. DOI 10.1155/2011/267539↗
- Mikio Kajihara · 2 shared papers, 2014 · strength 0.07
- Paper Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. DOI 10.1179/1973947813y.0000000150↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Kazuki Takakura · 2 shared papers, 2014 · strength 0.07
- Paper Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. DOI 10.1179/1973947813y.0000000150↗
- Paper Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restr… DOI 10.1158/1078-0432.ccr-14-0314↗
- Akitaka Takahara · 2 shared papers, 2011–2014 · strength 0.06
- Sadamu Homma · 2 shared papers, 2011–2014 · strength 0.05
- Yoichi Toyama · 1 shared paper, 2014 · strength 0.03
- Masato Okamoto · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.